全球藥物器械組合市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

全球藥物器械組合市場需求預計將從 2022 年的 2203.5 億美元達到 2030 年近 5048.8 億美元的市場規模，2023-2030 年研究期間年複合成長率為 10.92%。

藥物器械組合系統將一些醫療設備與藥物或生物成分整合在一起，以改善藥物輸送。這些產品作為單一實體發揮作用，以實現所需的功效，這在傳統的藥物輸送系統中通常是不存在的。組合產品必須經過嚴格的監管程序以維持安全和品質標準。由於這些項目包含來自不同監管團體的具有特定標準的組件，因此它們在監管許可期間受到持續監控。這些解決方案預計將代表多樣化、高度複雜的臨床技術和植入技術的功能增強。

市場動態：

因此，藥物-器械組合產品的經濟效益在全球範圍內越來越受歡迎和相關。醫療器械行業的快速擴張、慢性病患病率的上升以及新產品發布數量的激增是預計推動藥械組合產品需求的主要原因。此外，政府和私人對醫學研究的支持增加了研發投資，以及新興國家醫療保健意識的提高是預計推動全球醫療器械組合市場的幾個原因。然而，高昂的營運費用和後續工作以及有關藥物器械組合產品的限制性監管體係可能會阻礙市場成長。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球藥物器械組合市場的每個細分市場進行了包容性評估。藥物器械組合行業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的藥物器械組合市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。藥物器械組合市場的主要參與者包括 Abbott、Terumo Corporation、Stryker Corporation、Mylan NV、Medtronic、Allergan plc、Boston Scientific Corporation、Novartis AG、CR Bard、Teleflex Incorporated、WL Gore & Associates Inc。競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：藥物器械組合 - 行業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 行業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷管道發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球藥物器械組合市場分析：按產品

• 按產品概述
• 歷史和預測數據
• 按產品分析
• 輸液泵（容積式、拋棄式、注射器、流動式、植入式、胰島素）
• 骨科組合產品（骨移植植入物、抗生素骨水泥）
• 光動力治療儀
• 經皮貼劑
• 藥物洗脫支架（冠狀動脈支架、周邊血管支架）
• 傷口護理產品
• 吸入器（乾粉、霧化器、定量）
• 抗菌導管（泌尿、心血管、其他）
• 其他

第 7 章：全球藥物器械組合市場分析：按地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概述、歷史和預測銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家/地區銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家/地區銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳大利亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家/地區銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 8 章：藥物器械組合公司的競爭格局

• 藥物器械組合市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 9 章：公司簡介

• 頂級公司市場佔有率分析
• 市場集中度
• Abbott
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Terumo Corporation
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Stryker Corporation
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Mylan NV
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Medtronic
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Allergan plc
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Boston Scientific Corporation
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Novartis AG
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• CR Bard
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Teleflex Incorporated
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• WL Gore & Associates Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

The global demand for Drug Device Combination Market is presumed to reach the market size of nearly USD 504.88 BN by 2030 from USD 220.35 BN in 2022 with a CAGR of 10.92% under the study period 2023 - 2030.

Drug device combination systems integrate some medical equipment with medications or biological components to improve drug delivery. These products function as a single entity to achieve desired effectiveness, which is generally absent in conventional drug delivery systems. Combination products must undergo a rigorous regulatory procedure to maintain safety and quality standards. Because these items incorporate components from various regulatory groups with specific criteria, they are consistently monitored during regulatory clearances. These solutions are expected to represent a diverse, highly complex clinical technology and functional enhancements in implant technology.

MARKET DYNAMICS:

As a result, the financial benefits of drug-device combination products are increasing in popularity and relevance worldwide. Rapid expansion in the medical device industry, growing chronic illness prevalence, and an upsurge in the number of new product releases are the primary reasons expected to drive demand for drug-device combination products. Furthermore, government and private support for medical research increased R&D investment, and increased healthcare awareness in emerging nations are a few reasons anticipated to drive the worldwide medication device combination market. However, high operating expenses and follow-ups, as well as a restrictive regulatory system concerning drug-device combination products, can hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of drug device combination. The growth and trends of drug device combination industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the drug device combination market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, Insulin)
• Orthopedic Combination Products (Bone Graft Implants, Antibiotic Bone Cement)
• Photodynamic Therapy Devices
• Transdermal Patches
• Drug Eluting Stents (Coronary Stents, Peripheral Vascular Stents)
• Wound Care Products
• Inhalers (Dry Powder, Nebulizers, Metered Dose)
• Antimicrobial Catheters (Urological, Cardiovascular, Others)
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Drug Device Combination market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the drug device combination market include Abbott, Terumo Corporation, Stryker Corporation, Mylan N.V., Medtronic, Allergan plc, Boston Scientific Corporation, Novartis AG, C.R. Bard, Teleflex Incorporated, W. L. Gore & Associates Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . DRUG DEVICE COMBINATION - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL DRUG DEVICE COMBINATION MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, Insulin) Historic and Forecast Sales by Regions
• 6.5 Orthopedic Combination Products (Bone Graft Implants, Antibiotic Bone Cement) Historic and Forecast Sales by Regions
• 6.6 Photodynamic Therapy Devices Historic and Forecast Sales by Regions
• 6.7 Transdermal Patches Historic and Forecast Sales by Regions
• 6.8 Drug Eluting Stents (Coronary Stents, Peripheral Vascular Stents) Historic and Forecast Sales by Regions
• 6.9 Wound Care Products Historic and Forecast Sales by Regions
• 6.10. Inhalers (Dry Powder, Nebulizers, Metered Dose) Historic and Forecast Sales by Regions
• 6.11 Antimicrobial Catheters (Urological, Cardiovascular, Others) Historic and Forecast Sales by Regions
• 6.12 Others Historic and Forecast Sales by Regions

7 . GLOBAL DRUG DEVICE COMBINATION MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE DRUG DEVICE COMBINATION COMPANIES

• 8.1. Drug Device Combination Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF DRUG DEVICE COMBINATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Abbott
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Terumo Corporation
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Stryker Corporation
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Mylan N.V.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Medtronic
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. Allergan plc
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Boston Scientific Corporation
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Novartis AG
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. C.R. Bard
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments
• 9.12. Teleflex Incorporated
  • 9.12.1. Company Overview
  • 9.12.2. Company Revenue
  • 9.12.3. Products
  • 9.12.4. Recent Developments
• 9.13. W. L. Gore & Associates Inc.
  • 9.13.1. Company Overview
  • 9.13.2. Company Revenue
  • 9.13.3. Products
  • 9.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, Insulin) Market Sales by Geography (USD MN)
• Orthopedic Combination Products (Bone Graft Implants, Antibiotic Bone Cement) Market Sales by Geography (USD MN)
• Photodynamic Therapy Devices Market Sales by Geography (USD MN)
• Transdermal Patches Market Sales by Geography (USD MN)
• Drug Eluting Stents (Coronary Stents, Peripheral Vascular Stents) Market Sales by Geography (USD MN)
• Wound Care Products Market Sales by Geography (USD MN)
• Inhalers (Dry Powder, Nebulizers, Metered Dose) Market Sales by Geography (USD MN)
• Antimicrobial Catheters (Urological, Cardiovascular, Others) Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Drug Device Combination Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Drug Device Combination Report
• Market Research Process
• Market Research Methodology
• Global Drug Device Combination Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, Insulin) Market Sales by Geography (USD MN)
• Orthopedic Combination Products (Bone Graft Implants, Antibiotic Bone Cement) Market Sales by Geography (USD MN)
• Photodynamic Therapy Devices Market Sales by Geography (USD MN)
• Transdermal Patches Market Sales by Geography (USD MN)
• Drug Eluting Stents (Coronary Stents, Peripheral Vascular Stents) Market Sales by Geography (USD MN)
• Wound Care Products Market Sales by Geography (USD MN)
• Inhalers (Dry Powder, Nebulizers, Metered Dose) Market Sales by Geography (USD MN)
• Antimicrobial Catheters (Urological, Cardiovascular, Others) Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.